Lorazepam Injection Shortage: FDA Update
Areazine synthesizes this FDA drug-shortage notice directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Lorazepam Injection is currently in shortage due to increased demand, affecting some manufacturers, with the situation last updated in April 2026.
What this FDA drug-shortage notice tells you, and what most readers miss
This notice was issued by FDA on April 7, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are drug-shortage, fda, medication, Lorazepam Injection.
What's in Shortage
The generic drug Lorazepam Injection, with brand name LORAZEPAM, is in injection dosage form and falls under the therapeutic category of Neurology. Its current status is ongoing shortage, with the shortage first posted on 05/03/2018 and last updated on 04/02/2026.
Which Manufacturers Are Affected
- Amphastar Pharmaceuticals, Inc.: Availability is Limited Availability. Related info: Limited Availability. Presentation: Lorazepam, Injection, 2 mg/1 mL (NDC 76329-8261-1). Contact info: 800-423-4136.
- Fresenius Kabi USA, LLC: Availability is Available. Related info: Check wholesalers for inventory. Presentation: Lorazepam, Injection, 2 mg/1 mL (NDC 65219-368-02). Contact info: 888-386-1300.
Why There's a Shortage
The shortage is due to a demand increase for the drug.
What Patients Should Do
Patients experiencing issues with obtaining this medication should talk to their pharmacist or healthcare provider to discuss availability. They can also contact the manufacturer directly for more information. Please remember that patients should always consult their healthcare provider for any medical advice and not make changes to their treatment without professional guidance.
Source
This information is from the FDA Drug Shortage Database.
Original source: FDA Official Notice ↗
Related Drug Shortages
All Drug Shortages →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA drug-shortage notice: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,286 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to April 7, 2026.
Frequently Asked Questions
Common questions about this FDA drug-shortage notice.